Factors Associated With Successful Antipsychotic Dose Reduction in Schizophrenia: A Systematic Review of Prospective Clinical Trials and Meta-Analysis of Randomized Controlled Trials

被引：0
|
作者：
Tani, Hideaki [1 ]
Takasu, Shotaro [1 ]
Uchida, Hiroyuki [1 ]
Suzuki, Takefumi [1 ]
Nagai, Nobuhiro [1 ]
Mimura, Masaru [1 ]
Voineskos, Aristotle [1 ]
Takeuchi, Hiroyoshi [1 ]
Ikai-Tani, Saeko [1 ]
机构：
[1] Ctr Addict & Mental Hlth, Toronto, ON, Canada
来源：
NEUROPSYCHOPHARMACOLOGY | 2019年 / 44卷 / SUPPL 1期
关键词：
Antipsychotics; Dose Reduction; Maintenance Treatment; Schizophrenia;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
W168
引用
收藏
页码：475 / 475
页数：1
相关论文
共 50 条
  • [1] Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials
    Tani, Hideaki
    Takasu, Shotaro
    Uchida, Hiroyuki
    Suzuki, Takefumi
    Mimura, Masaru
    Takeuchi, Hiroyoshi
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (05) : 887 - 901
  • [2] Antipsychotic Trials in Schizophrenia from India: A Systematic Review and Meta-analysis
    Grover, S.
    Sarkar, S.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 77 (06) : 771 - 779
  • [3] Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: A meta-analysis and cochrane review of randomized controlled trials
    Dold, Markus
    Li, Chunbo
    Gillies, Donna
    Leucht, Stefan
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (09) : 1023 - 1033
  • [4] Antipsychotic Combinations vs Monotherapy in Schizophrenia: A Meta-analysis of Randomized Controlled Trials
    Correll, Christoph U.
    Rummel-Kluge, Christine
    Corves, Caroline
    Kane, John M.
    Leucht, Stefan
    SCHIZOPHRENIA BULLETIN, 2009, 35 (02) : 443 - 457
  • [5] Efficacy and tolerability of blonanserin in schizophrenia: A systematic review and meta-analysis of randomized controlled trials
    Tian, Jing
    Dong, Shimeng
    Nomura, Nobuyuki
    Siafis, Spyridon
    Lin, Xiao
    Wu, Hui
    Qin, Mengchang
    Yanagimoto, Hiroko
    Schneider-Thoma, Johannes
    Leucht, Stefan
    SCHIZOPHRENIA RESEARCH, 2024, 274 : 360 - 373
  • [6] Antipsychotic augmentation with modafinil or armodafinil for negative symptoms of schizophrenia: Systematic review and meta-analysis of randomized controlled trials
    Andrade, Chittaranjan
    Kisely, Steve
    Monteiro, Ingrid
    Rao, Sanjay
    JOURNAL OF PSYCHIATRIC RESEARCH, 2015, 60 : 14 - 21
  • [7] Adjunctive ondansetron for schizophrenia: A systematic review and meta-analysis of randomized controlled trials
    Zheng, Wei
    Cai, Dong-Bin
    Zhang, Qing-E.
    He, Jie
    Zhong, Li-Yun
    Sim, Kang
    Ungvari, Gabor S.
    Ning, Yu-Ping
    Xiang, Yu-Tao
    JOURNAL OF PSYCHIATRIC RESEARCH, 2019, 113 : 27 - 33
  • [8] Antipsychotic Medication in Adolescents Suffering from Schizophrenia: A Meta-Analysis of Randomized Controlled Trials
    Ardizzone, Ignazio
    Nardecchia, Francesca
    Marconi, Arianna
    Carratelli, Teresa I.
    Ferrara, Mauro
    PSYCHOPHARMACOLOGY BULLETIN, 2010, 43 (02) : 45 - 66
  • [9] tDose escalation of antipsychotic drugs in schizophrenia: A meta-analysis of randomized controlled trials
    Dold, Markus
    Fugger, Gernot
    Aigner, Martin
    Lanzenberger, Rupert
    Kasper, Siegfried
    SCHIZOPHRENIA RESEARCH, 2015, 166 (1-3) : 187 - 193
  • [10] Sarcosine as an add-on treatment to antipsychotic medication for people with schizophrenia: a systematic review and meta-analysis of randomized controlled trials
    Marchi, Mattia
    Galli, Giacomo
    Magarini, Federica Maria
    Mattei, Giorgio
    Galeazzi, Gian Maria
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (04) : 483 - 493
12345